Chronic diseases with the largest prevalence only account for a minority of the population on social media networks. Using the Internet to reach out to patients is economically unsound, as the costs of digital customer acquisition are prohibitive. As a result, communities of patients around a given chronic disease are highly fragmented and difficult for pharma companies to leverage. We are presenting an alternative method; by using the very packaging of a pharma product as a channel to reach out to patients with very high efficacy worldwide, marketing and patient management programs can connect with consumers at an impressively low cost.